newsfilter
← Latest News
GlobeNewswire·

Windtree Announces Istaroxime Exclusivity and Intellectual Property Potential Strategy for US

WARRINGTON, Pa., May 06, 2025 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. ("Windtree" or the "Company") (NasdaqCM: WINT), a biotechnology company focused on becoming a revenue generating company and advancing early